Sidoti Issues Pessimistic Estimate for USNA Earnings

USANA Health Sciences, Inc. (NYSE:USNA) – Investment analysts at Sidoti dropped their FY2027 EPS estimates for shares of USANA Health Sciences in a report released on Thursday, November 5th. Sidoti analyst A. Lebiedzinski now forecasts that the company will post earnings per share of $1.25 for the year, down from their previous estimate of $1.59. The consensus estimate for USANA Health Sciences’ current full-year earnings is $0.55 per share.

Other analysts have also issued research reports about the stock. Zacks Research lowered shares of USANA Health Sciences from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 4th. Wall Street Zen downgraded USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, September 21st. Two research analysts have rated the stock with a Sell rating. According to data from MarketBeat, USANA Health Sciences currently has an average rating of “Sell”.

USANA Health Sciences Price Performance

USNA opened at $13.86 on Tuesday. USANA Health Sciences has a one year low of $12.57 and a one year high of $23.59. The company’s 50 day simple moving average is $14.60 and its 200-day simple moving average is $17.91. The stock has a market capitalization of $256.13 million, a P/E ratio of -12.05, a price-to-earnings-growth ratio of 2.17 and a beta of 0.66.

USANA Health Sciences (NYSE:USNA) last announced its earnings results on Tuesday, November 3rd. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of $0.11 by ($0.22). USANA Health Sciences had a positive return on equity of 3.56% and a negative net margin of 2.34%. The company had revenue of $205.89 million during the quarter, compared to the consensus estimate of $217.42 million.

Hedge Funds Weigh In On USANA Health Sciences

Several hedge funds have recently added to or reduced their stakes in USNA. Versant Capital Management Inc lifted its stake in USANA Health Sciences by 1,472.3% in the second quarter. Versant Capital Management Inc now owns 1,588 shares of the company’s stock valued at $34,000 after buying an additional 1,487 shares during the period. GAMMA Investing LLC grew its position in shares of USANA Health Sciences by 689.4% during the 3rd quarter. GAMMA Investing LLC now owns 2,763 shares of the company’s stock worth $40,000 after buying an additional 2,413 shares during the period. State of Wyoming acquired a new position in shares of USANA Health Sciences during the 1st quarter worth about $57,000. GSA Capital Partners LLP acquired a new position in shares of USANA Health Sciences during the 2nd quarter worth about $250,000. Finally, State of Alaska Department of Revenue increased its stake in shares of USANA Health Sciences by 79.3% in the 3rd quarter. State of Alaska Department of Revenue now owns 11,950 shares of the company’s stock valued at $172,000 after acquiring an additional 5,284 shares during the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops and sells nutritional supplements, healthy foods and personal-care products through a direct-selling business model. Its product portfolio includes vitamins and mineral supplements, meal-replacement and snack products, sports nutrition offerings, and skincare products marketed under the USANA and related brands.

Founded in 1992 by microbiologist and immunologist Myron W. Wentz, the company is headquartered in Salt Lake City, Utah. USANA distributes its products through a network of independent associates and preferred customers rather than primarily through traditional retail channels.

The company serves customers in markets across the Americas, Asia-Pacific and Europe, with a significant presence in countries including the United States, Canada, Australia, New Zealand, China, Hong Kong, Japan, South Korea, the Philippines, Singapore, Malaysia and Thailand.